Biogen Inc.BIIBNASDAQ
Loading
Net Income Growth Under PressureDecelerating
Percentile Rank5
Year-over-Year Change
Year-over-year net income growth rate
Percentile
P5
Near historical low
vs 2Y Ago
-0.2x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -110.38% |
| Q3 2025 | -26.51% |
| Q2 2025 | 163.95% |
| Q1 2025 | -9.82% |
| Q4 2024 | -31.35% |
| Q3 2024 | -33.43% |
| Q2 2024 | 48.35% |
| Q1 2024 | 57.55% |
| Q4 2023 | 466.67% |
| Q3 2023 | -111.51% |
| Q2 2023 | 52.51% |
| Q1 2023 | -29.52% |
| Q4 2022 | -51.49% |
| Q3 2022 | 7.25% |
| Q2 2022 | 248.26% |
| Q1 2022 | -17.49% |
| Q4 2021 | 11.85% |
| Q3 2021 | -26.60% |
| Q2 2021 | 9.34% |
| Q1 2021 | 14.61% |
| Q4 2020 | -48.98% |
| Q3 2020 | -54.51% |
| Q2 2020 | 10.22% |
| Q1 2020 | -2.82% |
| Q4 2019 | -6.87% |
| Q3 2019 | 3.47% |
| Q2 2019 | 6.05% |
| Q1 2019 | 48.80% |
| Q4 2018 | -34.45% |
| Q3 2018 | 66.67% |
| Q2 2018 | -26.11% |
| Q1 2018 | 494.38% |
| Q4 2017 | -124.26% |
| Q3 2017 | 42.11% |
| Q2 2017 | 15.41% |
| Q1 2017 | 15.16% |
| Q4 2016 | -37.15% |
| Q3 2016 | -1.61% |
| Q2 2016 | 8.13% |
| Q1 2016 | 16.75% |